Consumer Information on: Raindrop® Near Vision Inlay

<!– –> <!– Page Last Updated: 09/09/2016 –> Page Last Updated: 09/09/2016 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Posted Ten New MDSAP Education Modules in the “Postmarket Activities” section of CDRH Learn

Premarket Notification (510k) The 510(k) ProgramPresentation    Printable Slides    Transcript Premarket Notification 510(k) OverviewPresentation    Printable Slides 510(k) Format Guidance, Including Standards Form, and Extensions/Clinical Trial Form and 510(k)Presentation    Printable Slides 510(k) Third Party ReviewPresentation    Printable Slides 510(k) Electronic Submission Pilot ProgramPrintable Slides   Transcript Two Draft Guidance Documents Clarifying When to Submit a 510(k) for a Change to…

MDSAP Invitation

%PDF-1.6% 49 0 objendobj 65 0 obj/Filter/FlateDecode/ID[]/Index[49 24]/Info 48 0 R/Length 77/Prev 479965/Root 50 0 R/Size 73/Type/XRef/W[1 2 1]stream hbbd“b` $;@D=k $X@,f~ Da”AJtAKAjF@#V?

The FDA recommends against using screening tests for ovarian cancer screening: FDA Safety Communication

Date Issued: September 7, 2016 Audience: Women and physicians Medical Specialty: Primary care, Obstetrics and Gynecology, Oncology, Gynecologic Oncology, Genetic Counseling Purpose: The FDA is alerting women about the risks associated with the use of tests being marketed as ovarian cancer screening tests. The Agency is especially concerned about delaying effective preventive treatments for women…

August 2016 PMA Approval List

%PDF-1.7 % 7877 0 obj stream x][s6~)V4″Vٲn:IyXcY’֌,n 2CjG76Ο?n?ŋhE4RZD)utbכ^xD2g?ن=,B”p,,$aًg$J$bL.4$=4o4^-竿?{u_’*kPFOlYVZ-^VMZJ%ML2݈IER͈3′}-CQ:vp_]^ {=sLQ^L sL˲N3#Y1F2FDfҞDCz 0d2lgy~eEti:gZ0I9,’Cei]f zm:L]”j”y,ˢm0i|37[“%8p$0

Mammography Facility Adverse Event and Action Report

<!– –> <!– Page Last Updated: 09/06/2016 –> Page Last Updated: 09/06/2016 <!– –> Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.

Essure

September 2015 Advisory Committee to discuss Essure Safety and Effectiveness The FDA has been examining safety concerns about Essure raised by patients and cited in Medical Device Reports (MDRs). We convened a meeting of the Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee on September 24, 2015 to: discuss currently available scientific…